UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,424,000 | +91.6% | 130,000 | +85.7% | 0.79% | +97.5% |
Q1 2022 | $1,265,000 | +1.6% | 70,000 | +73.3% | 0.40% | -23.2% |
Q2 2021 | $1,245,000 | -58.9% | 40,403 | -55.1% | 0.52% | -59.0% |
Q1 2021 | $3,032,000 | +29.1% | 90,000 | +38.5% | 1.26% | +6.7% |
Q4 2020 | $2,349,000 | -37.3% | 65,000 | -36.1% | 1.18% | -44.6% |
Q3 2020 | $3,748,000 | +18.8% | 101,766 | +45.4% | 2.14% | +1.4% |
Q2 2020 | $3,154,000 | -3.3% | 70,000 | -45.1% | 2.11% | -51.7% |
Q1 2020 | $3,263,000 | -78.7% | 127,500 | -30.7% | 4.36% | +88.7% |
Q4 2019 | $15,337,000 | – | 183,997 | – | 2.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |